Solid magnetoliposomes as multi-stimuli-responsive systems for controlled release of doxorubicin: assessment of lipid formulations

dc.contributor.authorCardoso, Beatriz D.por
dc.contributor.authorCardoso, Vanessa Fernandespor
dc.contributor.authorLanceros-Méndez, S.por
dc.contributor.authorCastanheira, Elisabete M. S.por
dc.date.accessioned2022-07-20T09:34:27Z
dc.date.available2022-07-20T09:34:27Z
dc.date.issued2022-05
dc.date.updated2022-07-19T08:25:31Z
dc.description.abstractStimuli-responsive liposomes are a class of nanocarriers whose drug release occurs, preferentially, when exposed to a specific biological environment, to an external stimulus, or both. This work is focused on the design of solid magnetoliposomes (SMLs) as lipid-based nanosystems aiming to obtain multi-stimuli-responsive vesicles for doxorubicin (DOX) controlled release in pathological areas under the action of thermal, magnetic, and pH stimuli. The effect of lipid combinations on structural, colloidal stability, and thermodynamic parameters were evaluated. The results confirmed the reproducibility for SMLs synthesis based on nine lipid formulations (combining DPPC, DSPC, CHEMS, DOPE and/or DSPE-PEG), with structural and colloidal properties suitable for biological applications. A loss of stability and thermosensitivity was observed for formulations containing dioleoylphosphatidylethanolamine (DOPE) lipid. SMLs PEGylation is an essential step to enhance both their long-term storage stability and stealth properties. DOX encapsulation (encapsulation efficiency ranging between 87% and 96%) in the bilayers lowered its pK(a), which favors the displacement of DOX from the acyl chains to the surface when changing from alkaline to acidic pH. The release profiles demonstrated a preferential release at acidic pH, more pronounced under mimetic mild-hyperthermia conditions (42 degrees C). Release kinetics varied with the lipid formulation, generally demonstrating hyperthermia temperatures and acidic pH as determining factors in DOX release; PEGylation was shown to act as a diffusion barrier on the SMLs surface. The integrated assessment and characterization of SMLs allows tuning lipid formulations that best respond to the needs for specific controlled release profiles of stimuli-responsive nanosystems as a multi-functional approach to cancer targeting and therapy.por
dc.description.sponsorshipThis research was funded by the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Funding UIDB/04650/2020, UIDB/04436/2020, UIDP/04436/2020 and through the research project PTDC/QUI-QFI/28020/2017 (POCI-01-0145-FEDER-028020), cofinanced by European Fund of Regional Development (FEDER), COMPETE2020 and Portugal2020. The authors also thank FCT for financial support under grants SFRH/BD/141936/2018 (B.D.C.) and 2020.02304.CEECIND (V.F.C.) Finally, the authors acknowledge funding by Spanish State Research Agency (AEI) and the European Regional Development Fund (ERFD) through the project PID2019106099RB-C43/AEI/10.13039/501100011033 and from the Basque Government Industry Departments under the ELKARTEK program.por
dc.distributioninternationalpor
dc.identifier.citationCardoso, B.D.; Cardoso, V.F.; Lanceros-Méndez, S.; Castanheira, E.M.S. Solid Magnetoliposomes as Multi-Stimuli-Responsive Systems for Controlled Release of Doxorubicin: Assessment of Lipid Formulations. Biomedicines 2022, 10, 1207. https://doi.org/10.3390/biomedicines10051207por
dc.identifier.doi10.3390/biomedicines10051207por
dc.identifier.eissn2227-9059
dc.identifier.urihttps://hdl.handle.net/1822/78855
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherMDPIpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04650%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04436%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F04436%2F2020/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/SFRH%2FBD%2F141936%2F2018/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/CEEC IND 3ed/2020.02304.CEECIND%2FCP1600%2FCT0025/PTpor
dc.relation.publisherversionhttps://www.mdpi.com/2227-9059/10/5/1207por
dc.rightsopenAccesspor
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/por
dc.subjectmagnetoliposomespor
dc.subjectstimuli-responsivepor
dc.subjectdrug deliverypor
dc.subjectdoxorubicinpor
dc.subjectcontrolled releasepor
dc.subject.wosScience & Technology
dc.titleSolid magnetoliposomes as multi-stimuli-responsive systems for controlled release of doxorubicin: assessment of lipid formulationspor
dc.typearticlepor
dspace.entity.typePublicationen
oaire.citationIssue5por
oaire.citationVolume10por
oaire.versionVoRpor
sdum.export.identifier12286
sdum.journalBiomedicinespor

Ficheiros

Pacote original

A mostrar 1 - 2 de 2
A carregar...
Nome:
biomedicines-10-01207-v2.pdf
Tamanho:
3.27 MB
Formato:
Adobe Portable Document Format
A carregar...
Nome:
Supplementary_Material.pdf
Tamanho:
504.77 KB
Formato:
Adobe Portable Document Format